Global Biospecimen Contract Research Services Market

Report ID : 1264 | Published : 2022-06-14 | Pages: | Format: PDF/EXCEL

The market size of the Global Biospecimen Contract Research Services Market is predicted to grow with a considerable CAGR of 9.3% during the forecast period. Increased investment in pharmaceutical R&D, an increase in the number of clinical trials, and the high cost of in-house drug development are driving growth in the Biospecimen Contract Research Services Market (encouraging pharma-biotech companies to outsource). Growth in the drugs and biologics market despite the COVID-19 pandemic, rising demand for specialized testing services among end-users, and the need for novel clinical trial designs for complex cell and gene therapies are all expected to provide a wide range of growth opportunities for market participants. Most pharmaceutical, biopharmaceutical, and medical device companies continue to invest heavily in developing new drugs and devices. In the pharmaceutical industry, R&D is essential, and pharmaceutical firms invest in research and development to bring high-quality, innovative products to market. The increased investment in biologics and biosimilars by biopharmaceutical companies is attributed to an increase in the number of approved products globally. Biologics like proteins, peptides, and monoclonal antibodies currently account for more than half of all drug candidates in the discovery stage.

Market Segmentation:

The Biospecimen Contract Research Services market is segmented into the biospecimen types and therapeutics areas. Based on the type of biospecimen types, the market is segmented into oncological and non-oncological studies. The oncological studies are further segmented into FFPE Tissue, Frozen Tissue, Plasma / Serum and Other Biospecimens. The non-oncological studies are further segmented into Blood Products, Human Tissue and Other Biospecimens. The therapeutics area segment includes Oncological Disorders, Neurological Disorders, Cardiovascular Disorders and Other Therapeutic Areas.

Based on Biospecimen Type, the oncological studies segment is accounted as a significant contributor in the Biospecimen Contract Research Services market.

The oncological studies segment is accounted as a significant contributor in the Biospecimen Contract Research Services market. The demand for biospecimens in cancer research has increased, but there is little data on biospecimen usage trends. These data are required to forecast future demand. This was due to larger cohort sizes for both frozen and FFPE tissues. For decades, Formalin-Fixed Paraffin-Embedded (FFPE) tissue specimens have been a mainstay of research and therapeutic applications. FFPE is a type of biopsy specimen preservation and preparation that aids in the examination, experimental research, and diagnostic/drug development. To preserve the proteins and vital structures within the tissue, a tissue sample is first fixed in formaldehyde, also known as formalin. It is then embedded in a paraffin wax block, making it easier to cut slices of the required sizes for examination on a microscopic slide.

The oncological disorders segment witnessed growth at a rapid rate.

Oncology, or the study of cancer and tumours, has made significant advancements in the prevention, treatment, and prognosis of many childhood cancers. Despite this progress, cancer remains the leading cause of death in children. Childhood cancer differs from adult cancers in terms of development, treatment, response to therapy, therapy tolerance, and prognosis. In most cases, childhood cancer responds better to treatment, the child can tolerate more aggressive treatment, and the forecast is better.

The North America Biospecimen Contract Research Services market holds a significant revenue share in the region.

North America dominated the global biospecimen contract research services market. North America's dominance in this market is primarily due to the market's rapid growth, pharmaceutical and biopharmaceutical companies' increased focus on outsourcing, and an increase in the number of clinical trial activities in the region. The rising popularity of precision/personalized medicine and genetic testing has been a major driving force in the region's market. Biobanks have long been essential in biomedical research. Over the last few decades, there have been several advancements in the platforms and tools used in genetic studies. This has resulted in increased clinical lab demand for biospecimens to develop assays for genetic testing in this region.

Competitive Landscape

The key players in the Biospecimen Contract Research Services market have shifted their focus towards bio-based components for product manufacturing and are initiating effective strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance product portfolio and strengthen their market footprint across the globe. Some of the major key players in the Biospecimen Contract Research Services market are BioChain Institute, BioIVT, Boca Biolistics, Creative Bioarray, Cureline, Discovery Life Sciences, Infinity BiologiX, Precision for Medicine, Inc., PrecisionMed, Inc., Medicover, National BioService, ICON plc, The MT Group, Eolas Biosciences Co. Ltd, Indivumed GmbH, Ardent Clinical Research Services, Capital Biosciences, Inc., GR BioResearch, REPROCELL, Trans-Hit Bio (Brooks Life Science Systems) and iSpecimen.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Biospecimen Contract Research Services Market Snapshot

Chapter 4. Global Biospecimen Contract Research Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 2: By Biospecimen Types Estimates & Trend Analysis

5.1. By Biospecimen Types & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Biospecimen Types:

5.2.1. Oncological Studies

5.2.1.1.  FFPE Tissue

5.2.1.2.  Frozen Tissue

5.2.1.3.  Plasma / Serum

5.2.1.4.  Other Biospecimens

5.2.2. Non-Oncological Studies

5.2.2.1.  Blood Products

5.2.2.2.  Human Tissue

5.2.2.3.  Other Biospecimens

Chapter 6. Market Segmentation 3: By Therapeutic Area Estimates & Trend Analysis

6.1. By Therapeutic Area & Market Share, 2020& 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Therapeutic Area:

6.2.1. Oncological Disorders

6.2.2. Neurological Disorders

6.2.3. Cardiovascular Disorders

6.2.4. Other Therapeutic Areas

Chapter 7. Biospecimen Contract Research Services Market Segmentation 4: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Biospecimen Contract Research Services Market revenue (US$ Million) estimates and forecasts By Biospecimen Types, 2019-2030

7.1.2. North America Biospecimen Contract Research Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2019-2030

7.1.3. North America Biospecimen Contract Research Services Market revenue (US$ Million) estimates and forecasts by country, 2019-2030

7.2. Europe

7.2.1. Europe Biospecimen Contract Research Services Market revenue (US$ Million) By Biospecimen Types, 2019-2030

7.2.2. Europe Biospecimen Contract Research Services Market revenue (US$ Million) By Therapeutic Area, 2019-2030

7.2.3. Europe Biospecimen Contract Research Services Market revenue (US$ Million) by country, 2019-2030

7.3. Asia Pacific

7.3.1. Asia Pacific Biospecimen Contract Research Services Market revenue (US$ Million) By Biospecimen Types, 2019-2030

7.3.2. Asia Pacific Biospecimen Contract Research Services Market revenue (US$ Million) By Therapeutic Area, 2019-2030

7.3.3. Asia Pacific Biospecimen Contract Research Services Market revenue (US$ Million) by country, 2019-2030

7.4. Latin America

7.4.1. Latin America Biospecimen Contract Research Services Market revenue (US$ Million) By Biospecimen Types, 2019-2030

7.4.2. Latin America Biospecimen Contract Research Services Market revenue (US$ Million) By Therapeutic Area, 2019-2030

7.4.3. Latin America Biospecimen Contract Research Services Market revenue (US$ Million) by country, 2019-2030

7.5. Middle East & Africa

7.5.1. Middle East & Africa Biospecimen Contract Research Services Market revenue (US$ Million) By Biospecimen Types, 2019-2030

7.5.2. Middle East & Africa Biospecimen Contract Research Services Market revenue2019-2030 By Therapeutic Area, 2019-2030

7.5.3. Middle East & Africa Biospecimen Contract Research Services Market revenue2019-2030 by country, 2019-2030

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. BioChain Institute

8.2.2. BioIVT

8.2.3. Boca Biolistics

8.2.4. Creative Bioarray

8.2.5. Cureline

8.2.6. Discovery Life Sciences

8.2.7. Infinity BiologiX

8.2.8. Precision for Medicine, Inc.

8.2.9. PrecisionMed, Inc.

8.2.10. Medicover

8.2.11. National BioService

8.2.12. ICON plc

8.2.13. The MT Group

8.2.14. Eolas Biosciences Co. Ltd

8.2.15. Indivumed GmbH

8.2.16. Ardent Clinical Research Services

8.2.17. Capital Biosciences, Inc.

8.2.18. GR BioResearch

8.2.19. REPROCELL

8.2.20. Trans-Hit Bio (Brooks Life Science Systems)

8.2.21. iSpecimen

8.2.22. Fidelis

8.2.23. GENETICIST INC

8.2.24. BIOMEDICA CRO

8.2.25. Circuit Clinical

8.2.26. Other Prominent Players

Segmentation of Biospecimen Contract Research Services Market-

By Biospecimen Types:

  • Oncological Studies
  • FFPE Tissue
  • Frozen Tissue
  • Plasma / Serum
  • Other Biospecimens
  • Non-Oncological Studies
  • Blood Products
  • Human Tissue
  • Other Biospecimens

By Therapeutic Area:

  • Oncological Disorders
  • Neurological Disorders
  • Cardiovascular Disorders
  • Other Therapeutic Areas

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients